We love stories like this, not only because they demonstrate the power of new medical device technologies, but also because they give us a window into the tactics employed by a company’s PR machine. In this case, SynCardia is adding to its long list of patients who’ve survived because of its total heart “bridge to transplantation”.
Omer Bayrak was first patient in Turkey to be discharged from the hospital with his SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver. While he continues to live at home with his family, waiting for a matching donor heart, Mr. Bayrak has returned to work and, as time allows, enjoys a little recreation.
So what better demonstration of the functionality, effectiveness and portability of its system than for Syncardia to show us the evidence in the image of Mr. Bayrak doing some off-roading over the summer.
Syncardia’s Turkish distributor followed up on the story by having Mr. Bayrak answer audience questions at the Turkish Society for Artificial Organs and Support Systems (TUYOD). He said he was “doing really well and very comfortable with SynCardia’s Total Artificial Heart.” He added that he is continuing his daily life with very few limitations.
There are seven SynCardia Certified Centers in Turkey, where 23 SynCardia Total Artificial Hearts have been implanted. Worldwide there are 87 SynCardia Certified Centers with an additional 33 Heart Centers in the process of certification.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. For now it remains limited by United States law to investigational use.
“I enjoy the outdoors and the Freedom driver lets me get out into the fresh air,” says Mr. Bayrak. “Being able to do anything I want is my biggest treasure.”
Source: SynCardia, Inc., PR Newswire